B. Riley analyst Jeff Van Sinderen raised the firm's price target on Zumiez to $18 from $14 and keeps a Neutral rating on the shares. Zumiez reported Q2 results above consensus estimates, delivering its fifth consecutive quarter of positive comparable sales growth with comps up 2.5%, driven primarily by North America's outperformance, the analyst tells investors in a research note. Quarter-to-date showed accelerating trends for peak back-to-school with sales up 10.6% and comps up 11.2%, representing a robust two-year comp stack of 23.3%, the firm adds.
